Last updated on August 2018

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

Brief description of study

The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE (Etoposide, Idarubicin, Trofosfamide) for 6 months improves the event free survival (EFS) in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma.

Clinical Study Identifier: NCT00876031

Contact Investigators or Research Sites near you

Start Over

Ewa Koscielniak, MD

Klinikum Augsburg
Augsburg, Germany
  Connect »